Cervical cancer: six years’ experience in a Colombian teaching hospital

Authors

  • Germán García-Soto
  • Juan de Jesús Pachón-Rincón
  • Ronald Smith Meneses-Cubides
  • John Jairo Zuleta-Tobón

DOI:

https://doi.org/10.18597/rcog.488

Keywords:

uterine cervical neoplasms, cytology, prevalence, Colombia

Abstract

Objective: the research was aimed at describing the health and socio-demographic characteristics of patients suffering from invasive cervical cancer who were attended at the San Vicente de Paul teaching hospital (SVPTH) in Medellin, Colombia, from 1997 to 2002.

Study design: this was a retrospective cohort study.

Population: every female patient attending SVPTH having a confirmed diagnosis of invasive cervical cancer 1997-2002 was included in the study.

Results: a total of 735 patients from 11 Colombian departments (mainly Antioquia, Chocó and Córdoba) were attended. 20.6% of these patients had a low educational level, most coming from poor areas. 24.5% had never sought having a Pap smear and only 20% had been diagnosed in stage I. The disease presented clinical behaviour similar to that described in previous studies.

Conclusions: a high level of poverty, low educational level, limited Pap smear application and predominance of the disease’s late stages was noticed in the cohort of patients being studied. Although SVPTH is a teaching hospital attending poor people,this scenario should call attention to a catastrophic disease which can and must be prevented.

Author Biographies

Germán García-Soto

Ginecólogo oncólogo. Profesor del grupo de Ginecología Oncológica. Universidad de Antioquia. 

Juan de Jesús Pachón-Rincón

Residente de III año de Obstetricia y Ginecología. Universidad de Antioquia.

Ronald Smith Meneses-Cubides

Residente de III año de Obstetricia y Ginecología. Universidad de Antioquia.

John Jairo Zuleta-Tobón

Obstetra y ginecólogo. Magíster en epidemiología clínica. Profesor del grupo de Ginecología General. Universidad de Antioquia.

References

Waxman AG. Guidelines for cervical cancer screening: history and scientific rationale. Clin Obstet Gynecol 2005;48:77-97.

Borrero M. Actualización en citología cervicovaginal. En: XI Curso de Actualización en Obstetricia y Ginecología. Universidad de Antioquia; 2003. p. 41-50.

Waggoner SE. Cer vical cancer. Lancet 2003;361:2217-25.

Morris M, Tortolero-Luna G, Malpica A. Neoplasia intraepitelial y cáncer cervicouterino. En: Clínicas de ginecología y obstetricia. Temas actuales. McGraw Hill Interamericana; 1996, Vol. 2. p. 315-73.

Krivac T, Mcbroom J. Cáncer cervicouterino y vaginal. En: Berek J. Ginecología de Novak. McGraw Hill Interamericana. 13ª edición; 2003. p. 959-87.

Lazcano-Ponce E, Alonso P, Ruiz-Moreno JA, Hernandez-Avila M. Recommendations for cervical cancer screening programs in developing countries. The need for equity and technological development. Salud Publica Mex 2003;45 Suppl 3:S449-62.

Globocan 2002 database. Cancer incidence, mortality and prevalence worldwide. http://wwwdep.iarc.fr/globocan/database.htm

Pardo C, Murillo R, Piñeros M, Castro MA. Casos nuevos de cáncer en el Instituto Nacional de Cancerología, Colombia, 2002. Rev Colomb Cancerol 2003;7:4-19.

Dirección Seccional de Salud de Antioquia. Registro poblacional de cáncer. [Visitado 2007, enero] Disponible en: http://www.dssa.gov.co/dowload/CANCER2005.pdf

Pinilla E, Uribe J, González G. Cáncer de cérvix IB. Análisis de 110 casos. Rev Colomb Obstet Ginecol 1988;39:186-90.

Arrossi S, Sankaranarayanan R, Parkin DM. Incidence and mortality of cervical cancer in Latin America. Salud Publica Mex 2003;45 Suppl 3:S306-14.

Gallego G, Uribe J, Ruiz IC. Carcinoma de cérvix en mujeres menores de 25 años. IATREIA1993;6:61-6.

Ministerio de Salud. Dirección General de Promoción y Prevención. Norma técnica para la detección temprana del cáncer de cuello uterino y guía de atención de lesiones preneoplásicas de cuello uterino. 2000.

ACOG Committee on Practice Bulletins. ACOG Practice Bulletin: clinical management guidelines for obstetriciangynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet Gynecol 2003;102:417-27.

Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-43.

Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.

Holtz DO, Dunton C. Tratamiento actual del cáncer cervicouterino invasor. En: Prevención de la mortalidad y morbilidad por cáncer cervicouterino. Clínicas de Ginecología y Obstetricia. Temas actuales. McGraw Hill Interamericana. Vol. 4, 2002. p. 645-56.

Hacker NF. Cervical cancer. En: Berek JS, Hacker NF. Practical gynecologic oncology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 380.

Eifel P. Radiation therapy. En: Practical gynecologic oncology, 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 146.

How to Cite

1.
García-Soto G, Pachón-Rincón J de J, Meneses-Cubides RS, Zuleta-Tobón JJ. Cervical cancer: six years’ experience in a Colombian teaching hospital. Rev. colomb. obstet. ginecol. [Internet]. 2007 Mar. 30 [cited 2024 May 18];58(1):21-7. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/488

Downloads

Download data is not yet available.

Published

2007-03-30

Issue

Section

Original Research
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views

Some similar items: